Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrronium vs penehyclidine before anesthesia for postoperative cognitive function in elderly hip arthroplasty
ChiCTR2300078825Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Zunyi Medical University
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of glycopyrronium in post-operative cognitive decline (POCD) and sleep disorder (2 arms), sponsored by Second Affiliated Hospital of Zunyi Medical University. Primary endpoints: Cognitive function, S100A12, IL-6, TNF-α levels and 2 more. Started Dec 2023; status: recruiting.
02
Drugs
glycopyrronium
03
Conditions
post-operative cognitive decline (POCD)sleep disorder
Beyond the preview
Go deeper on ChiCTR2300078825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078825.